Provided by Tiger Fintech (Singapore) Pte. Ltd.

Charles River Laboratories

149.79
-4.6900-3.04%
Post-market: 160.1010.31+6.88%19:25 EDT
Volume:1.06M
Turnover:158.23M
Market Cap:7.36B
PE:-242.32
High:155.69
Open:155.63
Low:146.26
Close:154.48
Loading ...

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform

Business Wire
·
25 Mar

ABEO: Countdown to PDUFA Date of April 29, 2025…

Zacks Small Cap Research
·
24 Mar

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Mar

Charles River Labs Cut to Neutral From Buy by Goldman Sachs

Dow Jones
·
21 Mar

Goldman Sachs Downgrades Charles River Laboratories International to Neutral From Buy, Adjusts Price Target to $170 From $190

MT Newswires Live
·
21 Mar

Charles River Labs (CRL) was downgraded to a Hold Rating at Goldman Sachs

TIPRANKS
·
21 Mar

3 Reasons CRL is Risky and 1 Stock to Buy Instead

StockStory
·
20 Mar

Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
20 Mar

Conduit Pharmaceuticals - Results for Study With Charles River Laboratories Expected in Q2 2025

THOMSON REUTERS
·
19 Mar

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Mar

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Mar

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
14 Mar

Should You Investigate Charles River Laboratories International, Inc. (NYSE:CRL) At US$171?

Simply Wall St.
·
13 Mar

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
12 Mar

TRVI Stock Soars on Meeting Primary Goal in Chronic Cough Study

Zacks
·
11 Mar

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Business Wire
·
11 Mar

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Operational Progress

Business Wire
·
08 Mar

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
06 Mar

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

StockStory
·
05 Mar

New Tengah and Seletar MRT lines being studied, could be operational from 2040s

CNA
·
05 Mar